No Effect of the 1α,25-Dihydroxyvitamin D(3) on β-Cell Residual Function and Insulin Requirement in Adults With New-Onset Type 1 Diabetes

OBJECTIVE: To determine whether daily intake of 1α,25-dihydroxyvitamin D(3) [1,25(OH)(2)D(3)] is safe and improves β-cell function in patients with recently diagnosed type 1 diabetes. RESEARCH DESIGN AND METHODS: Safety was assessed in an open study of 25 patients aged 18–39 years with recent-onset...

Descripción completa

Detalles Bibliográficos
Autores principales: Walter, Markus, Kaupper, Thomas, Adler, Kerstin, Foersch, Johannes, Bonifacio, Ezio, Ziegler, Anette-G.
Formato: Texto
Lenguaje:English
Publicado: American Diabetes Association 2010
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2890336/
https://www.ncbi.nlm.nih.gov/pubmed/20357369
http://dx.doi.org/10.2337/dc09-2297

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2890336/
https://www.ncbi.nlm.nih.gov/pubmed/20357369
http://dx.doi.org/10.2337/dc09-2297

Ejemplares similares